# FOXG1

## Overview
FOXG1 is a gene that encodes the forkhead box G1 protein, a transcription factor belonging to the forkhead family, characterized by a conserved forkhead DNA-binding domain. This protein plays a pivotal role in the development of the mammalian brain, particularly in the formation and function of the cerebral cortex. It is involved in regulating processes such as stem cell proliferation, regional patterning, cell migration, and circuit assembly through transcriptional and post-transcriptional mechanisms. The FOXG1 protein interacts with various other proteins and nucleic acids to modulate gene expression, forming complexes that are essential for its function in transcriptional repression. Mutations in the FOXG1 gene are linked to severe neurodevelopmental disorders, including FOXG1 syndrome and a congenital variant of Rett syndrome, highlighting its critical role in neurological development and function (Lu2022Identification; Wong2019FOXG1Related; Hou2020Transcription).

## Structure
The FOXG1 protein is a transcription factor belonging to the forkhead family, characterized by a highly conserved forkhead DNA-binding domain (FHD) consisting of 100 residues. This domain includes three alpha helices and one beta hairpin, which are typical features of the forkhead family (Florian2011<i>FOXG1<i>Related). The FOXG1 protein in humans is composed of 489 amino acids, with a conserved region from the forkhead binding domain to the C-terminus, while the N-terminal domain is more variable (Wong2019FOXG1Related).

In addition to the FHD, FOXG1 contains two other protein-binding domains: the KDM5B-binding domain (JBD) and the Gro-binding domain (GBD). These domains are involved in recruiting transcriptional corepressor proteins, and mutations in these regions can disrupt FOXG1 function (Florian2011<i>FOXG1<i>Related). The protein's localization is dynamic, shuttling between the nucleus and cytoplasm, which is regulated by Casein Kinase I and FGF signaling. This shuttling is crucial for its role in neuronal differentiation (Hou2020Transcription).

The FOXG1 protein also localizes to mitochondria, influencing mitochondrial function and neuronal differentiation. Specific amino acids (aa 277-302) are critical for this mitochondrial localization, which depends on membrane potential (Hou2020Transcription). The context does not provide detailed information on post-translational modifications or splice variant isoforms.

## Function
The FOXG1 gene encodes a transcription factor that plays a critical role in brain development, particularly in the formation and function of the mammalian cerebral cortex. It is involved in various processes such as stem cell proliferation, regional patterning, cell migration, and circuit assembly. FOXG1 regulates these processes through global transcriptional regulation via cis-regulatory elements in its target genes and fine-tuning at post-transcriptional levels through biochemical and epigenetic processes (Hou2020Transcription).

In healthy human cells, FOXG1 is crucial for regulating cell cycle progression and neuronal differentiation in neural progenitor cells. It represses cell cycle inhibitors like CDKN1B, CDKN1C, and CCNDBP1, while promoting the expression of cell cycle drivers such as CDC25A, MASTL, and CCND3, ensuring proper cell proliferation (Hettige2023FOXG1). FOXG1 also negatively regulates the TGF-ß/BMP signaling pathway by activating SMAD6 and SMAD7, maintaining the balance between proliferation and differentiation (Hettige2023FOXG1).

FOXG1's subcellular localization is dynamic, with nuclear localization in progenitor cells and cytoplasmic localization in differentiating cells. It also localizes to mitochondria, affecting mitochondrial function, which is important for neuronal differentiation (Hou2020Transcription).

## Clinical Significance
Mutations in the FOXG1 gene are associated with a range of severe neurodevelopmental disorders, including FOXG1 syndrome, which is characterized by developmental delays, intellectual disability, movement disorders, and epilepsy. These conditions often present with symptoms such as severe global developmental delay, cognitive impairment, hypotonia, and minimal or absent speech. Movement disorders like choreoathetosis and dystonia are common, and epilepsy is present in a significant proportion of affected individuals, often with seizures that are refractory to treatment (Wong2019FOXG1Related; Papandreou2016Delineation).

FOXG1 mutations are also linked to a congenital variant of Rett syndrome, which shares features with classic Rett syndrome but includes additional symptoms such as hypotonia and early developmental delays. These mutations can be de novo and include nonsense, missense, and frameshift mutations, as well as larger deletions and duplications (Lu2022Identification; Le2010A; Zhang2017Novel).

Alterations in FOXG1 expression levels can lead to ASD-like social impairments and are implicated in the development of certain cancers. The gene's role in brain development is crucial, and its dysregulation can result in a spectrum of neurological and developmental disorders (Lu2022Identification).

## Interactions
FOXG1, a transcription factor, engages in various interactions with proteins and nucleic acids to regulate gene expression. It forms transcription repression complexes with Groucho/Transducin-like Enhancer of split (TLE) proteins, utilizing the conserved C-terminal WD40 repeat domain of TLE proteins. This interaction is crucial for FOXG1's role in transcriptional repression and is mediated by the Gro-binding domain (GBD) of FOXG1 (i&gt; Florian2011&lt; Hettige2019FOXG1; FOXG1&lt; Yao2001The; Related).

FOXG1 also interacts with the basic helix-loop-helix protein Hes1 through TLE corepressors, enhancing Hes1's transcriptional repression capabilities (Yao2001The). It associates with histone deacetylase 1 (HDAC1) indirectly, likely mediated by TLE proteins, to recruit complexes that repress transcription (Yao2001The).

In addition to these interactions, FOXG1 binds with Lysine Demethylase 5B (KDM5B) through a conserved VP motif, which is important for regulating cell proliferation and differentiation during brain development (Hettige2019FOXG1). FOXG1's interaction with SMAD4 and FOXO1 complexes at the Cdkn1a promoter inhibits cell cycle exit and differentiation, highlighting its role in cell cycle regulation (Wong2019FOXG1Related).


## References


[1. (Lu2022Identification) Guanting Lu, Yan Zhang, Huiyun Xia, Xiaoyan He, Pei Xu, Lianying Wu, Ding Li, Liya Ma, Jin Wu, and Qiongling Peng. Identification of a de novo mutation of the foxg1 gene and comprehensive analysis for molecular factors in chinese foxg1-related encephalopathies. Frontiers in Molecular Neuroscience, December 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.1039990, doi:10.3389/fnmol.2022.1039990. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.1039990)

[2. (Wong2019FOXG1Related) Lee-Chin Wong, Shekhar Singh, Hsin-Pei Wang, Chia-Jui Hsu, Su-Ching Hu, and Wang-Tso Lee. Foxg1-related syndrome: from clinical to molecular genetics and pathogenic mechanisms. International Journal of Molecular Sciences, 20(17):4176, August 2019. URL: http://dx.doi.org/10.3390/ijms20174176, doi:10.3390/ijms20174176. This article has 53 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20174176)

[3. (Zhang2017Novel) Qingping Zhang, Jiaping Wang, Jiarui Li, Xinhua Bao, Ying Zhao, Xiaoying Zhang, Liping Wei, and Xiru Wu. Novel foxg1 mutations in chinese patients with rett syndrome or rett-like mental retardation. BMC Medical Genetics, August 2017. URL: http://dx.doi.org/10.1186/s12881-017-0455-y, doi:10.1186/s12881-017-0455-y. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12881-017-0455-y)

[4. (Hettige2019FOXG1) Nuwan C. Hettige and Carl Ernst. Foxg1 dose in brain development. Frontiers in Pediatrics, November 2019. URL: http://dx.doi.org/10.3389/fped.2019.00482, doi:10.3389/fped.2019.00482. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2019.00482)

[5. (Papandreou2016Delineation) Apostolos Papandreou, Ruth B. Schneider, Erika F. Augustine, Joanne Ng, Kshitij Mankad, Esther Meyer, Amy McTague, Adeline Ngoh, Cheryl Hemingway, Robert Robinson, Sophia M. Varadkar, Maria Kinali, Vincenzo Salpietro, Margaret C. O’Driscoll, S. Nigel Basheer, Richard I. Webster, Shekeeb S. Mohammad, Shpresa Pula, Marian McGowan, Natalie Trump, Lucy Jenkins, Frances Elmslie, Richard H. Scott, Jane A. Hurst, Belen Perez-Duenas, Alexander R. Paciorkowski, and Manju A. Kurian. Delineation of the movement disorders associated with foxg1 mutations. Neurology, 86(19):1794–1800, May 2016. URL: http://dx.doi.org/10.1212/wnl.0000000000002585, doi:10.1212/wnl.0000000000002585. This article has 56 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.0000000000002585)

[6. (Hou2020Transcription) Pei-Shan Hou, Darren Ó hAilín, Tanja Vogel, and Carina Hanashima. Transcription and beyond: delineating foxg1 function in cortical development and disorders. Frontiers in Cellular Neuroscience, February 2020. URL: http://dx.doi.org/10.3389/fncel.2020.00035, doi:10.3389/fncel.2020.00035. This article has 59 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2020.00035)

[7. (Hettige2023FOXG1) Nuwan C Hettige, Peter Fleming, Amelia Semenak, Xin Zhang, Huashan Peng, Marc-Daniel Hagel, Jean-François Théroux, Ying Zhang, Anjie Ni, Malvin Jefri, Lilit Antonyan, Shaima Alsuwaidi, Andreas Schuppert, Patrick S Stumpf, and Carl Ernst. Foxg1 targets bmp repressors and cell cycle inhibitors in human neural progenitor cells. Human Molecular Genetics, 32(15):2511–2522, May 2023. URL: http://dx.doi.org/10.1093/hmg/ddad089, doi:10.1093/hmg/ddad089. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddad089)

[8. (Le2010A) Tangui Le Guen, Nadia Bahi-Buisson, Juliette Nectoux, Nathalie Boddaert, Yann Fichou, Bertrand Diebold, Isabelle Desguerre, Florence Raqbi, Valérie Cormier Daire, Jamel Chelly, and Thierry Bienvenu. A foxg1 mutation in a boy with congenital variant of rett syndrome. neurogenetics, 12(1):1–8, August 2010. URL: http://dx.doi.org/10.1007/s10048-010-0255-4, doi:10.1007/s10048-010-0255-4. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-010-0255-4)

[9. (Yao2001The) Jing Yao, Eseng Lai, and Stefano Stifani. The winged-helix protein brain factor 1 interacts with groucho and hes proteins to repress transcription. Molecular and Cellular Biology, 21(6):1962–1972, March 2001. URL: http://dx.doi.org/10.1128/mcb.21.6.1962-1972.2001, doi:10.1128/mcb.21.6.1962-1972.2001. This article has 100 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.21.6.1962-1972.2001)